Compare CMG & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMG | KVUE |
|---|---|---|
| Founded | 1993 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Specialty Chemicals |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1B | 39.9B |
| IPO Year | 2006 | 2023 |
| Metric | CMG | KVUE |
|---|---|---|
| Price | $33.91 | $16.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 13 |
| Target Price | ★ $48.71 | $20.31 |
| AVG Volume (30 Days) | 22.8M | ★ 37.2M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 4.90% |
| EPS Growth | 4.56 | ★ 35.31 |
| EPS | ★ 1.13 | 0.75 |
| Revenue | $11,787,400,000.00 | ★ $15,006,000,000.00 |
| Revenue This Year | $6.29 | N/A |
| Revenue Next Year | $9.78 | $2.81 |
| P/E Ratio | $30.06 | ★ $22.64 |
| Revenue Growth | ★ 7.31 | N/A |
| 52 Week Low | $29.75 | $14.02 |
| 52 Week High | $66.74 | $25.17 |
| Indicator | CMG | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 50.23 | 55.31 |
| Support Level | $33.43 | $16.75 |
| Resistance Level | $34.59 | $17.19 |
| Average True Range (ATR) | 1.02 | 0.42 |
| MACD | 0.61 | 0.03 |
| Stochastic Oscillator | 74.92 | 60.56 |
Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $11.3 billion in 2024. The Mexican concept is almost exclusively company-owned, with just three license stores operated through a master franchise relationship with Alshaya Group in the Middle East. It had a footprint of 3,726 stores at the end of 2024, heavily indexed to the United States, although it maintains a small presence in Canada, the UK, France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.